Telcon RF Pharmaceutical (XKRX:200230) Operating Cash Flow per Share : ₩-99.59 (TTM As of Mar. 2025)

View and export this data going back to 2014. Start your Free Trial

What is Telcon RF Pharmaceutical Operating Cash Flow per Share?

Telcon RF Pharmaceutical's operating cash flow per share for the three months ended in Mar. 2025 was ₩-68.37. Telcon RF Pharmaceutical's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-99.59.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Telcon RF Pharmaceutical was -106.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Telcon RF Pharmaceutical's Operating Cash Flow per Share or its related term are showing as below:

During the past 12 years, Telcon RF Pharmaceutical's highest 3-Year average Operating Cash Flow per Share Growth Rate was 67.60% per year. The lowest was 67.60% per year. And the median was 67.60% per year.

XKRX:200230's 3-Year OCF Growth Rate is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 8.85
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Telcon RF Pharmaceutical Operating Cash Flow per Share Historical Data

The historical data trend for Telcon RF Pharmaceutical's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telcon RF Pharmaceutical Operating Cash Flow per Share Chart

Telcon RF Pharmaceutical Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Operating Cash Flow per Share

Get a 7-Day Free Trial

327.63

-40.82

-197.42

-97.83

103.04

Telcon RF Pharmaceutical Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Operating Cash Flow per Share	Get a 7-Day Free Trial															1,389.70	39.68	-33.01	-37.89	-68.37

Competitive Comparison of Telcon RF Pharmaceutical's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Telcon RF Pharmaceutical's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Telcon RF Pharmaceutical's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Telcon RF Pharmaceutical's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Telcon RF Pharmaceutical's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

Telcon RF Pharmaceutical Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Telcon RF Pharmaceutical's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )	=	Cash Flow from Operations (A: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2024 )
	=	1218.843	/	11.829
	=	103.04

Telcon RF Pharmaceutical's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Mar. 2025 )	=	Cash Flow from Operations (Q: Mar. 2025 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2025 )
	=	-821.553	/	12.017
	=	-68.37

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-99.59

Telcon RF Pharmaceutical Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Telcon RF Pharmaceutical's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Telcon RF Pharmaceutical Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Telcon RF Pharmaceutical Inc (XKRX:200230) » Definitions » Operating Cash Flow per Share

Traded in Other Exchanges

N/A

Address

684, Dongtangiheung-ro, Giheung-gu, Gyeonggi-do, Yongin-si, KOR, 17102

Website

http://www.telcon.co.kr

Telcon RF Pharmaceutical Inc manufactures wireless communication equipment. It develops connectors for input and output ports, board-to-board, cable assembly, and board-to-mount used in wireless communication equipment. The company also supplies RF coaxial connectors. The company operates in the RF Division and Pharmaceuticals & Biotechnology segments. The majority of its revenue is generated from Pharmaceuticals & Biotechnology, which produces and sells liquids, tablets, pills, capsules, etc.

Telcon RF Pharmaceutical Headlines

No Headlines